Results 171 to 180 of about 2,856,528 (208)

A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.

open access: yesClinical Microbiology and Infection, 2014
Jay W Hooper   +7 more
semanticscholar   +1 more source

DNA Vaccines Encoding HTNV GP-Derived Th Epitopes Benefited from a LAMP-Targeting Strategy and Established Cellular Immunoprotection. [PDF]

open access: yesVaccines (Basel)
Jiang D   +23 more
europepmc   +1 more source

DNA Vaccination/Genetic Vaccination

open access: yesJournal of Medical Microbiology, 1999
openaire   +1 more source

Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics. [PDF]

open access: yesActa Biochim Biophys Sin (Shanghai)
Tan D   +13 more
europepmc   +1 more source

Humoral and Cellular Immune Responses Induced by Bivalent DNA Vaccines Expressing Fusion Capsid Proteins of Porcine Circovirus Genotypes 2a and 2b. [PDF]

open access: yesVaccines (Basel)
Meas S   +6 more
europepmc   +1 more source

DNA vaccines

Current Opinion in Immunology, 1996
Preclinical DNA vaccine development has continued apace during the past year, with the investigation of several new infectious and non-infectious disease targets as well as advances in our understanding of some of the basic immunologic mechanisms, such as effector cells, responsible for conferring protection.
J B, Ulmer, J C, Sadoff, M A, Liu
  +11 more sources

DNA vaccines

Seminars in Immunology, 1997
DNA vaccines use eukaryotic expression vectors to produce immunizing proteins in the vaccinated host. Popular methods of delivery are intramuscular and intradermal saline injections of DNA and gene gun bombardment of skin with DNA-coated gold beads.
Robinson, Harriet L.   +1 more
  +9 more sources

Home - About - Disclaimer - Privacy